Vianex Group announces IDNA partnership

Vianex Group has recently entered into a strategic partnership with the Company through a substantial investment in the subsidiaries of the Group.

Demetris Giannakopoulos, President of the Board and CEO of VIANEX Group

“At VIANEX Group, as we go through the second century of our existence, we continue our constant search for innovative solutions in the field of health and medicine. We are very pleased to be able to expand our activities in the preventative medicine space by collaborating with iDNA, aiming to promote innovative and certified products that will make it easier for healthcare professionals to find personalized treatment for patients."

The partnership is expected to positively influence the results of iDNA Genomics Plc. The full announcement of the VIANEX Group is available on the company’s website here.